Werewolf Therapeutics, Inc.

NasdaqGS:HOWL 주식 보고서

시가총액: US$101.7m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Werewolf Therapeutics 미래 성장

Future 기준 확인 2/6

Werewolf Therapeutics 의 수익은 연간 17% 감소할 것으로 예상되는 반면, 연간 수익은 31% 로 증가할 것으로 예상됩니다. 31% 연간. EPS는 연간 6.3% 만큼 쇠퇴할 것으로 예상됩니다.

주요 정보

-16.8%

수익 성장률

-7.0%

EPS 성장률

Biotechs 수익 성장24.4%
매출 성장률31.0%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트26 Jun 2024

최근 미래 성장 업데이트

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 13
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Some Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shareholders Look For Exit As Shares Take 34% Pounding

Jun 04
Some Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shareholders Look For Exit As Shares Take 34% Pounding

Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space

Apr 04

Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Feb 07
Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Is Werewolf Therapeutics (NASDAQ:HOWL) A Risky Investment?

Jan 19
Is Werewolf Therapeutics (NASDAQ:HOWL) A Risky Investment?

There's No Escaping Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Muted Revenues Despite A 28% Share Price Rise

Dec 09
There's No Escaping Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Muted Revenues Despite A 28% Share Price Rise

Analysts Just Shipped A Captivating Upgrade To Their Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Estimates

Sep 30
Analysts Just Shipped A Captivating Upgrade To Their Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Estimates

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 13
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely

May 06
We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely

Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans

Jan 27
Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Rate

Oct 24
We're Not Very Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Rate

We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely

Jul 08
We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely

Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans

Mar 24
Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans

Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans

Dec 09
Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans

수익 및 매출 성장 예측

NasdaqGS:HOWL - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202613-87-53N/A4
12/31/202512-70-46N/A5
12/31/20243-68-63N/A5
3/31/202416-42-39-38N/A
12/31/202320-37-33-33N/A
9/30/202326-37-41-40N/A
6/30/202325-41-50-47N/A
3/31/202321-50-40-37N/A
12/31/202216-54-44-41N/A
9/30/20229-60-45-41N/A
6/30/20224-62-41-39N/A
3/31/2022N/A-115-50-50N/A
12/31/2021N/A-202-43-43N/A
9/30/2021N/A-205-36-36N/A
6/30/2021N/A-197-29-29N/A
3/31/2021N/A-127-23-23N/A
12/31/2020N/A-28-19-19N/A

애널리스트 미래 성장 예측

수입 대 저축률: HOWL 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: HOWL 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: HOWL 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: HOWL 의 수익(연간 31% ) US 시장( 8.7% 보다 빠르게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: HOWL 의 수익(연간 31% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: HOWL 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견